Eton Pharmaceuticals Inc. (ETON) Tops Q3 EPS by 8c

Eton Pharmaceuticals Inc. (NASDAQ: ETON) reported Q3 EPS of ($0.02), $0.08 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $7 million versus the consensus estimate of $6.26 million.

For earnings history and earnings-related data on Eton Pharmaceuticals Inc. (ETON) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• B.Riley Assumes Anika Therapeutics (ANIK) at Buy
• Element Solutions (ESI) PT Lowered to $47 at UBS, Buy Rating Maintained